The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:62A, October 2006
doi: 10.1176/appi.ajp.163.10.A62
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* October AJP Audio
* Residents' Journal
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Related Collections
*Related Articles

In This Issue

Metabolic Effects of Antipsychotics

A treatment study by Fenton and Chavez (p. 1697) discusses the care of patients who develop the metabolic syndrome while taking second-generation antipsychotic drugs. Obesity, hypertension, and abnormal lipid, triglyceride, and glucose levels can be managed through both lifestyle and medication. The psychiatrist’s role thus expands to include monitoring of weight and pertinent laboratory test results. The physiology behind the metabolic effects of second-generation antipsychotics is not clear, and risk varies among drugs. Olfson et al. (p. 1821) found that hyperlipidemia among California Medicaid recipients was most strongly associated with clozapine, followed by risperidone, quetiapine, olanzapine, ziprasidone, and first-generation antipsychotics. Aripiprazole did not increase risk.

Turning Attention to Adults With ADHD

Recognition that attention deficit hyperactivity disorder (ADHD) occurs in adults is helping refine illness characteristics. Faraone et al. (p. 1720) provide evidence that the diagnostic requirement of onset by age 7 could be modified to include late-onset cases. Adults with late-onset ADHD were similar to those with the full diagnosis in terms of co-occurring psychiatric disorders, familial transmission, and functional impairment. Biederman et al. (p. 1730) found that problems in executive functioning—how well the frontal cortex executes mental activities—were more common in adults with ADHD (31%) than in healthy subjects (16%). These deficits were associated with academic, work, and social dysfunction, conferring even greater disability than ADHD alone. In an editorial, Drs. James McGough and James McCracken (p. 1673) relate these findings to issues in diagnosis of ADHD.

Ingredients in Psychotherapy

An experimental study by Høglend et al. (p. 1739) suggests that patient attributes may help explain why different types of psychotherapy often produce seemingly equivalent outcomes. Patients received 1 year of dynamic psychotherapy with or without interpretations of "transference," the interaction between the patient and psychotherapist. The two forms of psychotherapy produced similar improvements overall. However, there was a difference for a subgroup of patients, those with poor interpersonal relationships, who unexpectedly benefited more from the therapy including transference interpretations. Dr. Glen Gabbard discusses this study in an editorial on p. 1667.

Wounds of War

Injury severity may be an important indicator of risk for posttraumatic stress disorder (PTSD), report Grieger et al. (p. 1777CME). Among 243 U.S. soldiers seriously injured in Iraq or Afghanistan, PTSD symptoms and physical symptoms at 1 month were associated with both PTSD and depression at 7 months. However, 79% of the soldiers with PTSD or depression at 7 months had not had either condition at 1 month.


Figure 1
View larger version (58K):
[in this window]
[in a new window]
 

FIGURE 1.



Gene-Behavior Crossroads

Three articles present genetic evidence for molecular mechanisms underlying specific clinical phenomena: cognitive dysfunction in schizophrenia, responsiveness to antipsychotic drugs, and mania as the presenting feature of bipolar disorder. Hirvonen et al. (p. 1747) demonstrated a genetic influence on dopamine transmission in the prefrontal cortex, which is related to cognitive deficits in schizophrenia. The unaffected monozygotic twins in pairs discordant for schizophrenia had higher densities of dopamine D1 receptors in the medial prefrontal cortex than healthy comparison subjects. This twin strategy allowed researchers to assess a genetic abnormality in dopamine receptors, free of the confounding effects of antipsychotic medication. Among patients receiving antipsychotic drugs, Reynolds et al. (p. 1826) found that one of three possible genotypes for a variable region of the serotonin 5-HT1A receptor gene was associated with greater improvement in negative and depressive symptoms than were the other two genotypes. Kassem et al. (p. 1754) report that manic onset of bipolar disorder is linked to chromosome 16p and that the polarity of the first episode (manic or depressive) is transmitted in families. A postmortem study by Paz et al. (p. 1829) presents evidence for cerebellar hyperactivity based on mRNA levels of three activity-dependent genes. As Kendler and Greenspan (p. 1683) describe, the genetic underpinnings of psychiatric illness have several commonalities with the genetics of behavior in "simpler" organisms, such as fruit flies and rodents. The editorial by Drs. David Lewis and Ahmad Hariri (p. 1676) provides further perspective on the field of psychiatric genetics.


Related Articles:

When Is Transference Work Useful in Dynamic Psychotherapy?
Glen O. Gabbard
Am J Psychiatry 2006 163: 1667-1669. [Full Text] [PDF]

Adult Attention Deficit Hyperactivity Disorder: Moving Beyond DSM-IV
James J. McGough and James T. McCracken
Am J Psychiatry 2006 163: 1673-1675. [Full Text] [PDF]

Genetics and the Future of Clinical Psychiatry
Ahmad R. Hariri and David A. Lewis
Am J Psychiatry 2006 163: 1676-1678. [Full Text] [PDF]

The Nature of Genetic Influences on Behavior: Lessons From "Simpler" Organisms
Kenneth S. Kendler and Ralph J. Greenspan
Am J Psychiatry 2006 163: 1683-1694. [Abstract] [Full Text] [PDF]

Medication-Induced Weight Gain and Dyslipidemia in Patients With Schizophrenia
Wayne S. Fenton and Mark R. Chavez
Am J Psychiatry 2006 163: 1697-1704. [Full Text] [PDF]

Diagnosing Adult Attention Deficit Hyperactivity Disorder: Are Late Onset and Subthreshold Diagnoses Valid?
Stephen V. Faraone, Joseph Biederman, Thomas Spencer, Eric Mick, Kate Murray, Carter Petty, Joel J. Adamson, and Michael C. Monuteaux
Am J Psychiatry 2006 163: 1720-1729. [Abstract] [Full Text] [PDF]

Impact of Psychometrically Defined Deficits of Executive Functioning in Adults With Attention Deficit Hyperactivity Disorder
Joseph Biederman, Carter Petty, Ronna Fried, Jessie Fontanella, Alysa E. Doyle, Larry J. Seidman, and Stephen V. Faraone
Am J Psychiatry 2006 163: 1730-1738. [Abstract] [Full Text] [PDF]

Analysis of the Patient-Therapist Relationship in Dynamic Psychotherapy: An Experimental Study of Transference Interpretations
Per Høglend, Svein Amlo, Alice Marble, Kjell-Petter Bøgwald, Øystein Sørbye, Mary Cosgrove Sjaastad, and Oscar Heyerdahl
Am J Psychiatry 2006 163: 1739-1746. [Abstract] [Full Text] [PDF]

Brain Dopamine D1 Receptors in Twins Discordant for Schizophrenia
Jussi Hirvonen, Theo G.M. van Erp, Jukka Huttunen, Sargo Aalto, Kjell Någren, Matti Huttunen, Jouko Lönnqvist, Jaakko Kaprio, Tyrone D. Cannon, and Jarmo Hietala
Am J Psychiatry 2006 163: 1747-1753. [Abstract] [Full Text] [PDF]

Familiality of Polarity at Illness Onset in Bipolar Affective Disorder
Layla Kassem, Victor Lopez, Don Hedeker, Jo Steele, Peter Zandi, NIMH Genetics Initiative Bipolar Disorder Consortium, NIMH Genetics Initiative Bipolar Disorder Consortium, and Francis J. McMahon
Am J Psychiatry 2006 163: 1754-1759. [Abstract] [Full Text] [PDF]

Posttraumatic Stress Disorder and Depression in Battle-Injured Soldiers
Thomas A. Grieger, Stephen J. Cozza, Robert J. Ursano, Charles Hoge, Patricia E. Martinez, Charles C. Engel, and Harold J. Wain
Am J Psychiatry 2006 163: 1777-1783. [Abstract] [Full Text] [PDF]

Hyperlipidemia Following Treatment With Antipsychotic Medications
Mark Olfson, Steven C. Marcus, Patricia Corey-Lisle, A.V. Tuomari, Patricia Hines, and Gilbert J. L’Italien
Am J Psychiatry 2006 163: 1821-1825. [Abstract] [Full Text] [PDF]

Effect of 5-HT1A Receptor Gene Polymorphism on Negative and Depressive Symptom Response to Antipsychotic Treatment of Drug-Naive Psychotic Patients
Gavin P. Reynolds, Belen Arranz, Lucy A. Templeman, Sofia Fertuzinhos, and Luis San
Am J Psychiatry 2006 163: 1826-1829. [Abstract] [Full Text] [PDF]

Increased Expression of Activity-Dependent Genes in Cerebellar Glutamatergic Neurons of Patients With Schizophrenia
Rodrigo D. Paz, Nancy C. Andreasen, Sami Z. Daoud, Robert Conley, Rosalinda Roberts, Juan Bustillo, and Nora I. Perrone-Bizzozero
Am J Psychiatry 2006 163: 1829-1831. [Abstract] [Full Text] [PDF]




This Article
* Full Text (PDF)
* October AJP Audio
* Residents' Journal
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Related Collections
*Related Articles


Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org